Evaluation of CPD MNV as an Aid in the Diagnosis and Risk Assessment of Sepsis (Protocol # Sepsis 1-14)

Sepsis, Severe Sepsis and Septic Shock Clinical Trial

— Beckman  

Official title:

Evaluation of CPD (Cell Population Data) MNV (Mean Neutrophil Volume) as an Aid in the Diagnosis and Risk Assessment of Sepsis (Protocol # Sepsis 1-14)

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02232750
• Other study ID #: 20141524
• Status: Completed
• Start date: July 14, 2014
• Est. completion date: August 15, 2015

Study information

• Verified date: November 2021
• Source: Ohio State University
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The investigators hypothesize that CPD parameters will provide improved prediction of sepsis compared to currently employed laboratory parameters. These studies hold the potential to shape practitioner guidelines and improve the timeliness and accuracy with which patients with sepsis are treated today.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 1320
• Est. completion date: August 15, 2015
• Est. primary completion date: August 15, 2015
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 90 Years

Eligibility

Inclusion Criteria:

• Adult (=18 to 90 years)

• Patients presenting to the Emergency Department

• CBC (Complete Blood Count) with differential testing performed and CPD data retrieved

Exclusion Criteria:

• Previously enrolled in this study

Related Conditions & MeSH terms

• Sepsis
• Sepsis, Severe Sepsis and Septic Shock
• Toxemia

Locations

Country	Name	City	State
United States	Wexner Medical Center at The Ohio State University	Columbus	Ohio

Sponsors (1)

Lead Sponsor	Collaborator
Ohio State University

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	We are measuring CBC (complete blood count) and MNV (Mean Neutrophil Volume)	Evaluate the clinical utility of CPD MNV as an aid in the diagnosis and risk assessment of Emergency Department patients for progression to sepsis, severe sepsis and septic shock.	approximately 10 months